相关实验视频
Updated: Feb 6, 2026
07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
4.4K
移植后儿科患者的电话康复运动计划:一项随机临床试验
Raquel P Carbonera1, Amanda Alves Luft2, Ana Clara Sobotyk2
1Graduate Program in Pediatrics: Child and Adolescent Care, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.
Pediatric nephrology (Berlin, Germany)
|February 4, 2026
概括
电话康复运动计划显著改善了儿科移植患者的功能能力. 这种安全和可行的干预措施显示了增强儿童移植后恢复和身体功能的前景.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 儿科康复儿童康复中心
- 运动生理学 运动生理学
背景情况:
- 患有慢性病 (CKD) 的儿童在移植 (KT) 后经常经历不完全的身体功能恢复.
- 电话康复提供了一种有前途的方法,可以改善儿科KT接受者遵守推的体育活动计划.
研究的目的:
- 评估电话康复运动计划对儿科脏移植接受者的功能能力的影响.
- 评估二次结果,包括外围肌肉强度,生活质量和干预的安全性.
主要方法:
- 一个单盲随机临床试验,涉及51名儿科移植接受者.
- 两个组:干预 (IG) 执行练习和控制 (CG) 执行呼吸练习,两者都远程进行六周.
- 通过修改的穿步行测试 (MSWT) 评估功能能力;外围肌肉强度和实验室测量也被评估.
主要成果:
- 干预组 (IG) 与对照组 (CG) (0.8米) 相比,MSWT距离 (90.6米) 显著增加.
- 两组都显示了外围肌肉力量的改善,在IG中观察到的收益更大.
- 在实验室测量中没有发现任何显著的变化;该计划被发现是可行的,并且在良好的遵守的情况下是安全的.
结论:
- 电话康复运动计划导致儿科脏移植接受者的功能能力显著改善.
- 虽然外围肌肉力量和生活质量在两组中都有所改善,但IG显示出更明显的好处.
- 该干预措施是安全的,可行的,并且得到了很好的遵守,表明其作为有效的移植后康复策略的潜力.
相关概念视频
01:16Clinical Trials
10.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.8K
01:11Clinical Trials: Overview
5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
01:28Kidney Transplant I: Introduction
481
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
481
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
266
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
314
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
314
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
236
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
236